COMP <GO>
ECG vs HD // ENTERPRISE SCALE & MARKET CAP
Everus Construction Group Inc. (NYSE) VS. Home Depot Inc. (NYSE) • 15-METRIC TALLY: ECG 4
— HD 10
▲ ENTERPRISE SCALE & MARKET CAP LEADER: HD
LAST: $102.99 (+0.35%) • MKT CAP: $5.24B
market-cap
$5.24B
LAST: $341.15 (+3.63%) • MKT CAP: $328.44B
market-cap
$328.44B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ECG VS. HD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ECG | HD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 12.10% | 33.30% | -21.20 | HD | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 30.40% | 32.90% | -2.50 | HD | /roic <GO> |
| EV/EBITDA & P/E Valuation | 13.7x | 13.4x | +0.30 | HD | /valuation <GO> |
| Free Cash Flow Yield | -0.21% | 2.72% | -2.93 | HD | /fcf-yield <GO> |
| Operating Margin | 7.10% | 12.70% | -5.60 | HD | /operating-margins <GO> |
| Net Profit Margin | 5.40% | 8.60% | -3.20 | HD | /net-margins <GO> |
| Revenue Growth (YoY) | 31.50% | 3.20% | +28.30 | ECG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.79% | -2.79 | HD | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 6.47 | 5.64 | +0.83 | ECG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 5/9 | +1.00 | ECG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.7 | 67.5 | -25.80 | HD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.13 | 0.88 | +0.25 | ECG | /macro-sensitivity <GO> |
| Forward P/E Multiple | 22.9x | 21.6x | +1.30 | HD | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $5.24B | $328.44B | -$323.20B | HD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ECG REV | HD REV | ECG GROSS % | HD GROSS % | ECG FCF | HD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.75B | $164.68B | 12.1% | 33.3% | -$11.7M | $8.91B |
| FY 2024 | $2.85B | $159.51B | 11.9% | 33.4% | $35.1M | $12.63B |
| FY 2023 | $2.85B | $152.67B | — | — | $42.9M | $14.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ECG // BETA 1.13
HD // BETA 0.88